How much revenue does Kubota Pharmaceutical Holdings make?

Kubota Pharmaceutical Holdings reported 21.34 million JPY in revenue for fiscal year 2025, down 21.5% from 27.19 million JPY in fiscal year 2024.

What companies are similar to Kubota Pharmaceutical Holdings?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Seed Co.,Ltd. (7743.T), Fuso Pharmaceutical Industries,Ltd. (4538.T), Renascience Inc. (4889.T), Sincere Co., Ltd. (7782.T).

Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) Stock

About Kubota Pharmaceutical Holdings Co., Ltd.

Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as pr...

At a glance

Kubota Pharmaceutical Holdings reported revenue of 21.34 million JPY for fiscal year 2025, down 21.5% from fiscal year 2024, and net income of -676.25 million JPY.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.